NCT00314509 - Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Asthma

Interventions

DRUG

Ciclesonide/Formoterol Combination

Trial Locations (26)

132

Altana Pharma/Nycomed, Arcadia, Pretoria

1125

Altana Pharma/Nycomed, Budapest

1529

Altana Pharma/Nycomed, Budapest

2660

Altana Pharma/Nycomed, Balassagyarmat

3233

Altana Pharma/Nycomed, Mátraháza

4043

Altana Pharma/Nycomed, Debrecen

4400

Altana Pharma/Nycomed, Nyíregyháza

5006

Altana Pharma/Nycomed, Szolnok

7500

Altana Pharma/Nycomed, Panorama / RSA-Cape Town

7505

Altana Pharma/Nycomed, Cape Town, Tygerberg

7530

Altana Pharma/Nycomed, Bellville, Cape Town

7925

Altana Pharma/Nycomed, Mowbray, Cape Town

8230

Altana Pharma/Nycomed, Balatonfüred

9024

Altana Pharma/Nycomed, Győr

9200

Altana Pharma/Nycomed, Mosonmagyaróvár

9300

Altana Pharma/Nycomed, Csorna

Altana Pharma/Nycomed, Bloemfontein

9700

Altana Pharma/Nycomed, Szombathely

14050

Altana Pharma/Nycomed, Berlin

15562

Altana Pharma/Nycomed, Rüdersdorf

22927

Altana Pharma/Nycomed, Großhansdorf

34295

Altana Pharma/Nycomed, Montpellier

38100

Altana Pharma/Nycomed, Grenoble

55131

Altana Pharma/Nycomed, Mainz

65187

Altana Pharma/Nycomed, Wiesbaden

Unknown

Altana Pharma/Nycomed, Pretoria